With the continuous pursuit of precision therapy in the biopharmaceutical field, targeting peptides-molecular tools that combine high specificity with excellent biocompatibility-are becoming important players in drug development, diagnostic reagents, and targeted delivery systems. We are committed to providing our clients with one-stop Targeting Peptide services, covering everything from target analysis and peptide sequence design to efficient screening and validation, helping you rapidly discover high-affinity and highly specific targeting peptides to drive breakthroughs in new drug development and precision medicine.
Leveraging advanced bioinformatics technologies, diverse peptide library construction platforms, and extensive screening experience, we offer customized and optimized Targeting Peptide solutions that cover all stages from basic research to preclinical development. Whether targeting cell surface receptors, enzymes, or pathology-related proteins, we provide professional and efficient Targeting Peptide design and screening services to support your research and industrialization process.
Design Targeting Peptide sequences based on the structure and function of target proteins, combined with bioinformatics tools
Use molecular docking simulations to predict peptide-target binding sites and affinities
Structural optimization to enhance peptide stability and specificity
Synthesize diverse random peptide libraries (linear peptide libraries, cyclic peptide libraries, constrained cyclic peptide libraries, etc.)
Design directed peptide libraries for specific targets
Synthesize peptide display vectors (such as phage display, bacterial display, peptide expression vectors)
Phage display technology to screen high-affinity targeting peptides
Yeast display technology for screening and characterization
Synthetic peptide microarray screening and binding analysis
Biophysical methods such as SPR (Surface Plasmon Resonance) and BLI (Biolayer Interferometry) to assist screening
Use SPR, BLI, ITC (Isothermal Titration Calorimetry), and other techniques to measure peptide-target binding constants
Cell surface binding analysis (flow cytometry, immunofluorescence, etc.)
In vitro cellular functional assays (cell uptake, competitive binding, signaling pathway activation/inhibition, etc.)
Intracellular localization studies
Targeting ability validation in animal models (immunohistochemistry, in vivo imaging, etc.)
Evaluate peptide enzymatic stability
Modification designs (cyclization, D-amino acid substitution, PEGylation, etc.) to improve stability and in vivo half-life
Metabolic pathway and biodistribution studies
Custom synthesis of Targeting Peptides to meet research and development needs
Various labeling methods including fluorescent, biotin, and radioactive labels
Design and synthesis of peptide linkers suitable for conjugation with drugs or nanocarriers
Provide Targeting Peptide screening and analysis reports combining bioinformatics and experimental data
Recommend peptide optimization strategies and directions for further development
Deeply understand the client's research goals and target information to clarify peptide screening requirements.
Design Targeting Peptide sequences based on the target's structure and function, and synthesize diverse peptide libraries (linear peptide libraries, cyclic peptide libraries, etc.).
Use technologies such as phage display, yeast display, or peptide microarrays for high-throughput screening and enrichment of high-affinity candidate peptides.
Measure peptide-target binding affinity using techniques like SPR and BLI, and validate targeting specificity via cell-based assays.
Optimize peptide structures based on validation results and evaluate their stability and functional performance.
Synthesize optimized Targeting Peptides and provide various functional modification services to meet subsequent R&D needs.
Provide detailed screening data and technical reports to assist clients in their subsequent development.
Used to discover high-affinity targeting peptides as active pharmaceutical ingredients or drug carriers.
Design targeting peptides against tumor markers for precise therapy and targeted delivery.
Applied in biomarker detection to assist early disease diagnosis.
Modify nanoparticles to achieve targeted delivery and improve drug targeting and bioavailability.
Develop peptides targeting immune cells to aid immunotherapy and vaccine optimization.
Used to deliver gene editing tools, nucleic acid drugs, etc., for cell-specific delivery.